Skip to content
Navigate to homepage - Cerba Research

Covid-19 samples available through Cerba Research IVD Division

In light of the global COVID-19 pandemic, the need for testing has become urgent and critical.  Cerba Research IVD, together with Cerba Laboratories, is widely using SARS-CoV-2 diagnostic tests to detect the virus in patients.

The national epidemiological situation has undergone changes demanding measures in favor of multiple diagnostic tests with health care providers who are capable of receiving large numbers of samples for the diagnosis of COVID-19.

As a major player in public health in the specialty diagnostics sector for more than 50 years, Cerba is receiving COVID-19 samples and performing 4000+ SARS-CoV-2 tests daily.

With the agreement of the French Health Directorate (DGS), we are performing COVID-19 diagnostic tests for confirmation of positive cases in the support of the CNR responsible for respiratory infections at the Institut Pasteur (Paris).

With our expansive access to patient samples, Cerba Research IVD can help support the development of diagnostics tests for both molecular and immunological assays.

For COVID-19 samples – nasopharyngeal (NPS) or serological samples, please contact our team at [email protected].

For COVID-19 assay validation – testing evaluation or method comparison testing – please contact our team at [email protected].

Additional Resources: